Trinity Pharma Proprietary Limited (Trinity), a step-down subsidiary of Strides Pharma Science Limited in South Africa, has availed credit facility from Investec for Business, a division of Investec Bank Limited, South Africa, for their working capital requirements of Rs. 31.5 crore.
DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a full offering of commercialization services for medical technology (MedTech) companies with the launch of their new MedTech Center of Excellence. Trinity has a been working with MedTech companies since its inception more than 25 years ago, but this new Center of Excellence formalizes its offerings to this sector of the life sciences industry.
WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest white paper entitled “Beyond Vaccines – How Monoclonal Antibodies Can Help in the Fight Against the COVID-19 Pandemic.” The paper finds that while there are still unknowns about monoclonal antibodies, such as real-life efficacy and long-term effects, they have the potential to effectively target several stages of the COVID-19 disease with evident benefits at a patient level (by alleviating symptoms and preventing progression to severe disease) and at a systemic level (by reducing the strain on the world’s overburdened health systems).
Russia plans to share preliminary results of its Covid-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic.